Top-down control of the descending pain modulatory system drives multimodal placebo analgesia.

Cortical and brainstem circuits, especially the ventrolateral periaqueductal gray, causally mediate multimodal placebo analgesia in mice, with lasting effects after injury.

• Why it matters: Understanding the neural basis of placebo analgesia addresses a critical gap in pain management and could improve clinical strategies by harnessing endogenous pain relief mechanisms.
• What they did: The study used a mouse model of placebo conditioning, revealing that cortical inputs to the vlPAG and endogenous opioid release are essential for suppressing pain behaviors and generalizing to different pain types.
• The result: Findings demonstrate that activating this central circuit produces durable placebo analgesia, suggesting that preventive conditioning could enhance resilience to pain in clinical settings.